/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme). Urbanek L, Schmidt B, Bordignon S, Schaack D, et al. J Cardiovasc Electrophysiol 2024 May 15. doi: 10.1111/jce.16302.">
/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme)." />
/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme).
J Cardiovasc Electrophysiol. 2024 May 15. doi: 10.1111/jce.16302. " />
Read + Share
Urbanek L, Schmidt B, Bordignon S, Schaack D, et al. Cryoablation of atrial fibrillation in "very severe" obese patients (BMI >/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme). J Cardiovasc Electrophysiol 2024 May 15. doi: 10.1111/jce.16302.
PMID: 38750671
/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme).&body=Cryoablation of atrial fibrillation in "very severe" obese patients (BMI >/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme). Urbanek L, Schmidt B, Bordignon S, Schaack D, et al. J Cardiovasc Electrophysiol 2024 May 15. doi: 10.1111/jce.16302. https://m.amedeo.com/38750671 " ALT="Email" TITLE="Email">Email
/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme).&summary=Urbanek L, Schmidt B, Bordignon S, Schaack D, et al. Cryoablation of atrial fibrillation in "very severe" obese patients (BMI >/= 40):
Indications, feasibility, procedural safety and efficacy, and clinical outcome
(the ICE-Obese Extreme). J Cardiovasc Electrophysiol 2024 May 15. doi: 10.1111/jce.16302.&source=https://m.amedeo.com" target="linkedin">LinkedIn
Privacy Policy